| 25th Oct 2022 7:00 am |
RNS |
Change of name to hVIVO plc effective |
| 20th Oct 2022 7:00 am |
RNS |
Capital Markets Day |
| 18th Oct 2022 7:00 am |
RNS |
CFO appointment & change of Board roles |
| 30th Sep 2022 7:00 am |
RNS |
Positive in vitro results for FLU-v published |
| 29th Sep 2022 9:30 am |
RNS |
Director dealings |
| 27th Sep 2022 7:00 am |
RNS |
Upcoming Scientific Presentations |
| 15th Sep 2022 7:00 am |
RNS |
Comment regarding press speculation |
| 8th Sep 2022 7:01 am |
RNS |
Interim results and trading update |
| 8th Sep 2022 7:00 am |
RNS |
Intention to change name to hVIVO plc |
| 1st Sep 2022 7:20 am |
RNS |
CAP accreditation |
| 25th Aug 2022 7:00 am |
RNS |
Notice of results |
| 22nd Aug 2022 7:00 am |
RNS |
£10.4m contract with existing Big Pharma client |
| 4th Aug 2022 7:00 am |
RNS |
£6.2m Influenza human challenge study contract |
| 5th Jul 2022 1:17 pm |
RNS |
Result of AGM |
| 30th Jun 2022 7:00 am |
RNS |
Omicron human challenge model |
| 14th Jun 2022 7:00 am |
RNS |
£7.2m RSV human challenge study contract |
| 10th Jun 2022 12:13 pm |
RNS |
Board appointment amendment |
| 10th Jun 2022 12:00 pm |
RNS |
Annual Report and Notice of AGM |
| 8th Jun 2022 7:00 am |
RNS |
Board appointment |
| 7th Jun 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 7th Jun 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 7th Jun 2022 7:00 am |
RNS |
Final results |
| 1st Jun 2022 7:00 am |
RNS |
GBP14.7m influenza contract signed |
| 26th May 2022 7:00 am |
RNS |
Completion of Nominated Adviser due diligence |
| 24th May 2022 7:00 am |
RNS |
Notice of results |
| 18th May 2022 7:00 am |
RNS |
£7.3m Influenza human challenge study contract win |
| 12th May 2022 7:00 am |
RNS |
Wellcome publication |
| 5th May 2022 7:00 am |
RNS |
Vaccine field study contract |
| 4th May 2022 7:00 am |
RNS |
Challenge virus manufacturing contract |
| 4th May 2022 7:00 am |
RNS |
Comment re: speculation |
| 28th Apr 2022 7:00 am |
RNS |
Appointment of Nominated Adviser and Joint Broker |
| 13th Apr 2022 7:00 am |
RNS |
Proposal to Distribution in Specie Shareholders |
| 12th Apr 2022 12:00 pm |
RNS |
Presentation at World Vaccine Congress |
| 6th Apr 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 6th Apr 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 6th Apr 2022 2:01 pm |
RNS |
Price Monitoring Extension |
| 6th Apr 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 6th Apr 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 31st Mar 2022 10:05 am |
RNS |
Characterisation Study results in Nature Medicine |
| 25th Mar 2022 7:00 am |
RNS |
£5m RSV human challenge study contract win |
